Despite heightened geopolitical tensions in the Middle East dominating headlines in 2026, investor attention is increasingly turning toward the potential revival of the initial public offering market.

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going in 2026?

Defense tech startups are on a tear, which became clear this week when shares of AI drone company Swarmer soared 520% in ...

China has moved to stop “low-quality” companies from listing in Hong Kong as it seeks to slow but not halt an IPO boom. The ...

Innovision's ₹319.25 crore IPO faces weak demand, not fully subscribed after six days. The price range was adjusted to ₹494- ...

A couple of years ago, design software firm Canva was one of the hot startups to watch, on everyone’s list of IPO candidates. But it sat out last year’s IPO class and now finds itself in an awkward ...

India’s IPO market is set for a busy week with seven new issues, including Sai Parenteral and Powerica, along with four upcoming listings. This week’s calendar ...

Market volatility and geopolitical tensions have choked liquidity in India’s IPO market, forcing high‑profile companies to hit pause.

Hong Kong plans to expand its “name-and-shame” regime for sloppy listing applications to include law firms and auditors, ...

By Danial Azhar and Yantoultra Ngui KUALA LUMPUR/SINGAPORE, March 18 (Reuters) - Malaysia's Sunway Healthcare Holdings surged 28% on its market debut on Wednesday, after raising 2.86 billion ringgit ...

As of August 2025, PhonePe has over 65 crore (650+ million) registered users and a digital payments acceptance network spread ...